LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: The changing profile of SARS-CoV-2 serology in Irish blood donors.

    Coyne, Dermot / Butler, Dearbhla / Meehan, Adrienne / Keogh, Evan / Williams, Pádraig / Carterson, Alex / Hervig, Tor / O'Flaherty, Niamh / Waters, Allison

    Global epidemiology

    2023  Volume 5, Page(s) 100108

    Abstract: Background: The present study aimed to investigate the progression of the SARS-CoV-2 pandemic in Ireland over the first three waves of infection.: Method: A selection of blood donor serum samples collected between February 2020 and December 2021 were ...

    Abstract Background: The present study aimed to investigate the progression of the SARS-CoV-2 pandemic in Ireland over the first three waves of infection.
    Method: A selection of blood donor serum samples collected between February 2020 and December 2021 were analysed by various commercially available serological assays for antibodies to SARS-CoV-2 (
    Results: An increase in seropositivity was observed between wave 1 (February to September 2020) and wave 2 (November and December 2020) of 2.20% to 3.55%. A large increase in estimated seroprevalence to 11.89% was observed in samples collected in February and March 2021 (wave 3 of infection).The rate of seropositivity varied by age group, with the highest rate observed in the youngest donors (18-29 years) peaking at 18.79% in wave 3. The results of spike antibody (anti-S) testing indicated that 44/1009 (4.36%) of seroreactive donors in wave 3 had a serological profile consistent with vaccination. By November 2021, we detected an overall seropositivity of 97.04%.
    Conclusions: The present study provides a comprehensive estimation of the level of circulating SARS-CoV-2 antibodies in Irish blood donors, enabling differentiation between vaccination and natural infection, as well as real-time monitoring of the progression of the COVID-19 pandemic in Ireland. Seroepidemiology has a role in determining reliable estimates of transmission, infection fatality rates and vaccine uptake. The continued screening of blood donors for this purpose has the potential to generate important data to assist with the management of future waves of SARS-CoV-2.
    Language English
    Publishing date 2023-04-21
    Publishing country United States
    Document type Journal Article
    ISSN 2590-1133
    ISSN (online) 2590-1133
    DOI 10.1016/j.gloepi.2023.100108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection.

    Butler, Dearbhla / Coyne, Dermot / Pomeroy, Louise / Williams, Pádraig / Holder, Paul / Carterson, Alex / Field, Stephen / Waters, Allison / O'Flaherty, Niamh

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2021  Volume 146, Page(s) 105045

    Abstract: Introduction: Blood donor studies offer a unique opportunity to screen healthy populations for the presence of antibodies to emerging infections. We describe the use of blood donor specimens to track the 'first-wave' of the COVID-19 pandemic in Ireland.! ...

    Abstract Introduction: Blood donor studies offer a unique opportunity to screen healthy populations for the presence of antibodies to emerging infections. We describe the use of blood donor specimens to track the 'first-wave' of the COVID-19 pandemic in Ireland.
    Methodology: A random selection of donor samples received by the Irish Blood Transfusion Service (IBTS) between February and September 2020 (n = 8,509) were screened by multiple commercial SARs-CoV-2 antibody assays. The antibody detection rate was adjusted to the population to determine the SARS-CoV-2 seroprevalence in Ireland.
    Results: SARS-CoV-2 antibody detection rose significantly during the first peak of COVID-19 infection, increasing from 0.3% in March, to 2.9% in April (p < 0.0001, The first SARS-CoV-2 antibody positive donor samples were collected on the 17th February 2020, 2 weeks prior to the first official notification. This is the earliest serological evidence of SARS-CoV-2 circulating in the Irish population. Our results also show a significantly higher antibody prevalence in the Capital city and in donors less than 40 years of age.
    Conclusions: The present study demonstrates evidence of SARS-CoV-2 antibody reactivity across all age groups and counties. The critical value of blood donor seroprevalence studies is apparent in this report which identified the earliest serological evidence of SARS-CoV-2 infection in Ireland, as well as documenting the evolution of COVID-19 pandemic in Ireland over time.
    MeSH term(s) Antibodies, Viral ; Blood Donors ; COVID-19 ; Humans ; Pandemics ; SARS-CoV-2 ; Seroepidemiologic Studies
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2021-11-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2021.105045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top